Acute coronary syndrome as the first symptom of vasospastic angina – case report of a 38-year-old man with myocardial infarction with non-obstructive coronary artery disease
More details
Hide details
1
Department of Cardiology, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland
2
Centre of Postgraduate Medical Education, Warsaw, Poland
Corresponding author
Łukasz Gabryel
Klinika Kardiologii, Państwowy Instytut Medyczny MSWiA, ul. Wołoska 137, 02-507 Warszawa
Ann. Acad. Med. Siles. 2024;78:304-308
KEYWORDS
TOPICS
ABSTRACT
A 38-year-old obese man with hypertension and a twenty-year history of nicotinism was admitted for a suspected ST-segment elevation myocardial infarction (STEMI). Coronary angiography did not reveal significant coronary artery stenosis, which, together with symptoms of acute coronary syndrome and increased troponin I levels, led to the diagnosis of myocardial infarction with non-obstructive coronary artery disease (MINOCA) and implied a differential diagnosis. Given the clinical picture, a provocative test with acetylcholine was performed, which indicated the vasoconstrictive origin of MINOCA. In order to reduce the likelihood of another episode, pharmacotherapy was changed and lifestyle changes were recommended.
REFERENCES (9)
1.
Byrne R.A., Rossello X., Coughlan J.J., Barbato E., Berry C., Chieffo A. et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur. Heart J. 2023; 44(38): 3720–3826, doi: 10.1093/eurheartj/ehad191.
2.
Knuuti J., Wijns W., Saraste A., Capodanno D., Barbato E., Funck-Brentano C. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 2020; 41(3): 407–477, doi: 10.1093/eurheartj/ehz425.
3.
Prinzmetal M., Kennamer R, Merliss R., Wada T., Bor N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am. J. Med. 1959; 27: 375–388, doi: 10.1016/0002-9343(59)90003-8.
4.
Lanza G.A., Careri G., Crea F. Mechanisms of coronary artery spasm. Circulation 2011; 124(16): 1774–1782, doi: 10.1161/CIRCULATIONAHA.111.037283.
5.
Marrone A., Pavasini R., Scollo E., Gibiino F., Pompei G., Caglioni S. et al. Acetylcholine use in modern cardiac catheterization laboratories: A systematic review. J. Clin. Med. 2022; 11(4): 1129, doi: 10.3390/jcm11041129.
6.
Hokimoto S., Kaikita K., Yasuda S., Tsujita K., Ishihara M., Matoba T. et al. JCS/CVIT/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction. Circ. J. 2023; 87(6): 879–936, doi: 10.1253/circj.CJ-22-0779.
7.
Montone R.A., Meucci M.C., De Vita A., Lanza G.A., Niccoli G. Coronary provocative tests in the catheterization laboratory: Pathophysiological bases, methodological considerations and clinical implications. Atherosclerosis 2021; 318: 14–21, doi: 10.1016/j.atherosclerosis.2020.12.008.
8.
Shibata K., Wakabayashi K., Ikeda N., Ishinaga T., Kusakabe Y., Masaki A. et al. Clinical implications of atrial fibrillation provoked by acetylcholine. Circ. Arrhythm. Electrophysiol. 2024; 17(9): e013015, doi: 10.1161/CIRCEP.124.013015.
9.
Rehan R., Weaver J., Yong A. Coronary vasospastic angina: A review of the pathogenesis, diagnosis, and management. Life 2022; 12(8): 1124, doi: 10.3390/life12081124.